Celgene Expands Use of Medidata’s Technology
Celgene has expanded its eight-year technology relationship with Medidata to add the Medidata Clinical Cloud® as its enterprise technology platform.
Medidata announced that Celgene has expanded its eight-year technology relationship with Medidata to add the Medidata Clinical Cloud® as its enterprise technology platform for all clinical trials worldwide. A Medidata Rave customer since 2008, Celgene will now include Medidata Designer® (study and protocol design); Medidata Grants Manager® (site budgeting and planning); Safety Gateway (safety reporting); Medidata CTMS® (clinical trial management); Medidata SQM® (site quality management) and Medidata Patient Cloud ePRO (electronic patient-reported outcomes). Celgene is also leveraging one of Medidata’s clinical analytics offerings, Medidata Insights, which provides advanced metrics, visualizations and industry data and benchmarks.
Read the full release.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
